Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Alper H.YUKSEL who wrote (29998)	1/9/2000 11:48:00 AM
From: Torben Noerup Nielsen	Read Replies (1) \| Respond to of 32384

Alper, My guess is that we could sail through $20 in the next several months. Yes, I'm assuming that the breast cancer results will be positive and that Targretin sales ramp up fast. If Henry is right and it'll be on the shelves by the end of the month, the sales representatives are already loading their trunks with literature and samples. They're going to have a very busy time of it. And I'm sure they're received all sorts of lectures as to what they're allowed to say on their visits. As I recall, the sales force is now up to 40. For any kind of sales force, you have to have at least something like $500K worth of sales per person for it all to make sense and it had better be a good deal higher than that. The low end of the sales figures is probably realistic for this year. But given the expected growth, the multiples awarded by the market might be quite high. It should definitely be higher than the average figure I used. Also, if it does indeed look like we're heading for profitability this year, we should see some real price appreciation. Historically, the market likes to give a stock major appreciation in the year it is turning profitable. And with any luck, that is this year. By the way, if Ligand does turn profitable this year, they'll have a significant kitty in the bank that they can spend on something and I wonder what they'll spend it on. I'm afraid to mention it, but Robinson has talked about another acquisition in the past... Thanks, Torben

To: Alper H.YUKSEL who wrote (29998)	1/9/2000 12:09:00 PM
From: Torben Noerup Nielsen	Read Replies (1) \| Respond to of 32384

Alper, By the way, if we cross $20 by June, the party will be on New Year's Eve of the real millennium :-) My feeling is that if we're going to make a significant move this year, it has to occur in the first 6 months. Ligand has said that they expect the data from the ABC trials in the first 6 months and if they are to keep the market's attention, they need to deliver on that. And all that is needed is a significant improvement on current therapies. That'll generate the necessary thrust. As I mentioned before, I'd like something like an Atlas 5 thruster; they work ever so well and once ignited, they have enough thrust to reach get us close to escape velocity! Cheers, Torben